Low-intensity focused ultrasound-assisted dox-piperine amplified therapy on anaplastic thyroid carcinoma by hybird tumor-targeting nanoparticles

Lingyu Zhu,Qimeihui Wang,Guoqing Sui,Dengke Teng,Hequn Li,Yang Wang,Peng Dong,Haitao Ran,Zhigang Wang,Hui Wang

DOI: https://doi.org/10.1016/j.jddst.2023.104202

IF: 5

2023-01-25

Journal of Drug Delivery Science and Technology

Abstract:Highlights • The core of the newly assembled carrier for controlled release was PAMAM-Dox, release of Dox triggered by LIFU, which can achieve accumulation in tumor region to counter the efflux effect caused by MDR. • Piperine, a kind of traditional Chinese medicine, the extact of black pepper, was loaded at the bilayer lipid membrane as the shell of the nanoparticles and played a role as a competitive substrate to bind to ABC transit system to against the efflux of Dox and beneficial to the treatment. • Another substance loaded on the shell was IR-780, which served as photoacoustic (PA) imaging contrast agent and a tumor-targeting element in the treatment. Therapies against anaplastic thyroid carcinoma (ATC) have been sticking in the predicament of multiple drug resistance (MDR). To address multiple drug resistance and promote therapeutic efficiency, we developed a novel nanoparticle with properties of spatial-temporally controlled release based on poly (amido amine) dendrimers-G4(PAMAM-G4) & Low-intensity focused ultrasound (LIFU) and synergistic killing effect by the combination of Dox and Piperine (PIP). Methods We synthesized a core-shell-structured nanoparticle named by thin film hydration-sonoseismic method, where the core was consisted of PAMAM-G4 encapsulating Dox and the shell was formed by IR780-PIP-co-loaded bilayer lipid membrane. The therapeutic efficacy and biosafety of nanoparticles were evaluated by cell experiments and xenograft tumor nude mouse model experiments. Results Data showed that, with the intervention by LIFU, tumor-targeting dual-drug-loaded nanoparticles termed as exhibited superior therapeutic effect over non-tumor-targeting dual-drug-loaded nanoparticles termed as and remarkable advantages over non-tumor-targeting Dox-loaded-only nanoparticles termed as PAMAM-Dox, both in vitro and in vivo. With the addition of IR780, NPs showed reduced side effects caused by drug-leakage, enhanced tumor-specific therapeutic effects and granted praiseworthy PA imaging capacity. Moreover, possesses sound biocompatibility and biosafety. Conclusion has yielded great prospects in future treatment of anaplastic thyroid carcinoma and the potential of visualized therapy.

pharmacology & pharmacy